Modulation of cell cycle control by vitamin D3 and its analogue, EB1089, in human breast cancer cells

Gengfei Wu, Robert S. Fan, Wenhui Li, Tien C. Ko, Michael G. Brattain

Research output: Contribution to journalArticlepeer-review

103 Scopus citations


Examination of a panel of ER positive breast cancer cell lines showed that they were differentially growth inhibited by vitamin D3 and its analogue EB1089. EB1089 treatment of the breast cancer cell lines MCF- 7 E, BT20, T47D, and ZR75 demonstrated a correlation between a reduction in Cdk2 kinase activity towards phosphorylation of histone H1 and a decrease in DNA synthesis, while no modulation of CdkZ activity was observed in the vitamin D3 and EB1089 resistant cell line MCF-7 L. This was accompanied by a time dependent decrease in the percentage of S phase cells in the responsive lines. Characterization of the expression levels of Cdk2 and its related cell cycle proteins in MCF-7 E cells showed that after EB1089 treatment, there was a concentration and time dependent up-regulation of p21 as well as a decrease in cyclin A proteins. Paradoxically, cyclin E levels were increased as a function of treatment. Analysis of cyclin-Cdk2-Cdki complex formation showed that in EB1089 treated MCF-7 E cells, Cdk2, cyclin A and cyclin E immunoprecipitates contained an increased abundance of p21. In contrast to MCF-7 E cells, increases in both p21 and p27 as well as their complex formation with Cdk2 were observed in BT20 and ZR75 cells. These findings indicate that up-regulation of p21 as well as p27 in some cell types may account for the inactivation of Cdk2 activity and a G1 block of the cell cycle following EB1089 treatment.

Original languageEnglish (US)
Pages (from-to)1555-1563
Number of pages9
Issue number13
StatePublished - 1997
Externally publishedYes


  • Breast cancer
  • EB1089
  • Inactivation of Cdk2 activity
  • Vitamin D
  • p21(WAF-1/CIP-1)

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research


Dive into the research topics of 'Modulation of cell cycle control by vitamin D3 and its analogue, EB1089, in human breast cancer cells'. Together they form a unique fingerprint.

Cite this